TrialImmunity2017

Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma.

Suzanne George et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.